Our laboratory studies the behavior of human auditory stem cells and is trying to develop a therapeutic approach to treat hearing loss. We have identified and isolated a population of multipotent otic stem cells from the human fetal cochlea and established them as cell lines.
We have devised ways of directing differentiation of human embryonic stem cells into auditory phenotypes and also working with adult populations such as induced-pluripotency and bone marrow stem cells. The potential of auditory stem cells to repair the damaged cochlea is tested in vivo by transplantation experiments using mammalian models for hearing loss and we are also exploring their use in combination with cochlear implants.
Studying the use of hESC-derived otic neuroprogenitors in vivo, in combination with cochlear implants.
Email: L.Abbas@sheffield.ac.uk
Manipulation of signalling pathways that control growth and differentiation of human auditory stem cells using small molecules
Inducing otic differentiation from adult stem cell populations; i.e. bone marrow-derived mesenchymal stem cells.
Email: S.L.Boddy@sheffield.ac.uk
Controlled differentiation of hESC-derived otic progenitors.
Email: mdp08sj@sheffield.ac.uk
Molecular profiling and comparison of auditory stem cells from mice and humans.
Email: mdp06aln@sheffield.ac.uk
Gene delivery and expression in human auditory stem cells using transposable vectors.
Email: m.pannella@sheffield.ac.uk
Differentiation of human iPS cells into otic phenotypes.
Email: mdp08rr@sheffield.ac.uk
Whole transcriptome analysis of hESC-derived otic progenitors.
Email: J.Thurlow@sheffield.ac.uk